Estech signs drug export deal

Published: 2008-11-17 06:43:00

Updated: 2008-11-17 06:43:00

Local active pharmaceutical ingredient (API) maker Estech Pharma signed a contract with India's largest pharmaceutical company on November 10 to export Planlukast, an antiarthmatic medicine.

The deal with Ranbaxy Laboratories Ltd. is in the scale of $7.3 million for five years.

The deal al...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK